Accepted for/Published in: JMIR Pediatrics and Parenting
Date Submitted: Aug 21, 2020
Date Accepted: Sep 25, 2020
Date Submitted to PubMed: Oct 5, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Patient and Clinician Perspectives on Adolescent Opioid Use Disorder Treatment During a Pandemic: One step back, but two forward?
ABSTRACT
Opioid use disorder (OUD) is one of the most pressing public problems in the United States and is highly prevalent among adolescents and young adults (AYAs). However, only a small percentage AYAs with OUD ever receive treatment. Further, among those that do receive treatment, a substantial proportion of patients continue to struggle with OUD and many prematurely drop out of treatment. These challenges have only heightened in the face of the COVID-19 pandemic, but greater utilization of telehealth and mobile technologies by OUD patients may help counter these barriers, which ultimately may improve AYA OUD treatment post-pandemic. This viewpoint presents the perspective of a person in OUD recovery using online and mobile technology to supports his own OUD recovery combined with thoughts from two clinicians supporting AYAs with OUD; their perspectives may provide insights to help counter COVID-19 related consequences and offer clues to improving AYD OUD treatment long-term.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.